Milena Adamian MD, PhD

Dr. Milena Adamian brings a unique perspective as a clinician and academic researcher enriched by industry and investment experience. Over 25 years of her career, Dr. Adamian split time equally between leadership and investment roles, including Boston Scientific Corporation (NYSE: BSC), Lehman Brothers, Easton Capital Partners, Azimuth Ventures, and Owlet Baby Care. Azimuth Ventures originated from the Life Sciences Angel Network (LSAN), where, in addition to leading seed investment in portfolio companies, she single-handedly organized and ran two annual conferences for investors focused on medical devices and healthcare technology.

Milena’s past and present investments and Board involvements include Xoft (now NYSE: ICAD), Cardiovascular Systems (now NYSE: CSII), Forge Medical, Comprehend Systems, Common Sensing, BioTrace Medical, AvhanaHealth, ZappRX, Wellframe, Owlet Baby Care, and Stasis Labs. Milena Adamian was named to the TechWeek100 2014 list of Leaders in NYC with significant impact on business and technology, Women of Influence Honoree 2015 by New York Business Journal, and Woman of Impact 2017 by Impactmania. Dr. Adamian is a member of the American College of Cardiology, She authored and co-authored 29 scientific peer-reviewed manuscripts.